Elevate Uranium Stock Buy Hold or Sell Recommendation
| ELVUF Stock | USD 0.18 0.02 10.00% |
Assuming the 90 days horizon and complete risk avoidance on your part, our recommendation regarding Elevate Uranium is 'Strong Sell'. Macroaxis provides Elevate Uranium buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ELVUF positions.
Check out Elevate Uranium Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Elevate and provide practical buy, sell, or hold advice based on investors' constraints. Elevate Uranium. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in employment.
Elevate |
Execute Elevate Uranium Buy or Sell Advice
The Elevate recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Elevate Uranium. Macroaxis does not own or have any residual interests in Elevate Uranium or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Elevate Uranium's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Responds to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Elevate Uranium Trading Alerts and Improvement Suggestions
| Elevate Uranium had very high historical volatility over the last 90 days | |
| Elevate Uranium has some characteristics of a very speculative penny stock | |
| Elevate Uranium has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 116.86 K. Net Loss for the year was (5.73 M) with profit before overhead, payroll, taxes, and interest of 116.86 K. | |
| Elevate Uranium has accumulated about 15.81 M in cash with (4.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. | |
| Roughly 17.0% of the company shares are held by company insiders |
Elevate Uranium Returns Distribution Density
The distribution of Elevate Uranium's historical returns is an attempt to chart the uncertainty of Elevate Uranium's future price movements. The chart of the probability distribution of Elevate Uranium daily returns describes the distribution of returns around its average expected value. We use Elevate Uranium price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Elevate Uranium returns is essential to provide solid investment advice for Elevate Uranium.
| Mean Return | 0.20 | Value At Risk | -14.29 | Potential Upside | 11.54 | Standard Deviation | 8.79 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Elevate Uranium historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Elevate Uranium Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Elevate Uranium or Energy sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Elevate Uranium's price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Elevate otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.02 | |
β | Beta against Dow Jones | 1.33 | |
σ | Overall volatility | 8.71 | |
Ir | Information ratio | 0.01 |
Elevate Uranium Volatility Alert
Elevate Uranium is showing large volatility of returns over the selected time horizon. Elevate Uranium is a potential penny stock. Although Elevate Uranium may be in fact a good instrument to invest, many penny otc stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Elevate Uranium. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Elevate instrument if you perfectly time your entry and exit. However, remember that penny otcs that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Elevate Uranium Fundamentals Vs Peers
Comparing Elevate Uranium's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Elevate Uranium's direct or indirect competition across all of the common fundamentals between Elevate Uranium and the related equities. This way, we can detect undervalued stocks with similar characteristics as Elevate Uranium or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Elevate Uranium's fundamental indicators could also be used in its relative valuation, which is a method of valuing Elevate Uranium by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Elevate Uranium to competition |
| Fundamentals | Elevate Uranium | Peer Average |
| Return On Equity | -0.41 | -0.31 |
| Return On Asset | -0.24 | -0.14 |
| Current Valuation | 59.41 M | 16.62 B |
| Shares Outstanding | 275.5 M | 571.82 M |
| Shares Owned By Insiders | 16.66 % | 10.09 % |
| Shares Owned By Institutions | 10.13 % | 39.21 % |
| Price To Book | 5.94 X | 9.51 X |
| Price To Sales | 1,137 X | 11.42 X |
| Revenue | 116.86 K | 9.43 B |
| Gross Profit | 116.86 K | 27.38 B |
| EBITDA | (5.69 M) | 3.9 B |
| Net Income | (5.73 M) | 570.98 M |
| Cash And Equivalents | 15.81 M | 2.7 B |
| Cash Per Share | 0.06 X | 5.01 X |
| Total Debt | 177.27 K | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 23.53 X | 2.16 X |
| Book Value Per Share | 0.07 X | 1.93 K |
| Cash Flow From Operations | (4.38 M) | 971.22 M |
| Earnings Per Share | (0.01) X | 3.12 X |
| Number Of Employees | 5 | 18.84 K |
| Beta | 1.02 | -0.15 |
| Market Capitalization | 84.11 M | 19.03 B |
| Total Asset | 19.33 M | 29.47 B |
| Net Asset | 19.33 M |
Elevate Uranium Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Elevate . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.9 | |||
| Day Median Price | 0.18 | |||
| Day Typical Price | 0.18 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.02) |
About Elevate Uranium Buy or Sell Advice
When is the right time to buy or sell Elevate Uranium? Buying financial instruments such as Elevate OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Elevate Uranium in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Healthcare Funds Thematic Idea Now
Healthcare Funds
Funds or Etfs investing in medical and healthcare goods or services as well as hospital management or maintenance organizations. The Healthcare Funds theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Elevate OTC Stock
Elevate Uranium financial ratios help investors to determine whether Elevate OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Elevate with respect to the benefits of owning Elevate Uranium security.